
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Semaglutide
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase IV
Sponsor : Ali Aminian
Deal Size : Inapplicable
Deal Type : Inapplicable
Bariatric Surgery vs. Semaglutide vs. Tirzepatide
Details : Semaglutide is a Peptide drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Obesity.
Product Name : Undisclosed
Product Type : Peptide, Unconjugated
Upfront Cash : Inapplicable
January 31, 2025
Lead Product(s) : Semaglutide
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase IV
Sponsor : Ali Aminian
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study
Details : Fibrin Sealant is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 21, 2017
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

The EVICEL® Neurosurgery Phase III Study
Details : Evicel (Fibrin Sealant) is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cerebrospinal Fluid Leak.
Product Name : Evicel
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 29, 2015

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Paediatric EVICEL® Neuro Study
Details : Evicel (Fibrin Sealant) is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cerebrospinal Fluid Otorrhea.
Product Name : Evicel
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 05, 2014
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study
Details : Fibrin Sealant is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hemorrhage.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 28, 2014
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study
Details : Evicel (Fibrin Sealant) is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hemorrhage.
Product Name : Evicel
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 28, 2014
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Thrombin
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : Johnson & Johnson
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Thrombin is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hemorrhage.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 24, 2014
Lead Product(s) : Thrombin
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : Johnson & Johnson
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Fibrin Pad CV Phase III Study
Details : Fibrin Sealant is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cardiovascular Diseases.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 20, 2014
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Thrombin
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : Johnson & Johnson
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase IV Bioseal Study in Brain Tumor Surgery
Details : Thrombin is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hemostasis.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 14, 2014
Lead Product(s) : Thrombin
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : Johnson & Johnson
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The EVARREST® Fibrin Sealant Patch Liver Study
Details : Fibrin Sealant is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hemorrhage.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 25, 2013
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
